ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bullish•CSL Ltd
•16 Sep 2023 22:56

CSL Ltd (CSL AU): Banking on Strong Growth in Immunoglobulin Franchise on Record Plasma Collection

​In FY23, plasma volume grew 31%, while plasma collection cost declined ~14% YoY and down 17% from the peak. In FY24, revenue and profit are...

Logo
652 Views
Share
•12 Sep 2023 06:30

Australia: S&P/ASX, REMX, GDXJ, MVA, MVW & Other Index Flows on Friday

There are a bunch of rebalances that will be implemented in Australia on Friday. Nearly 100 stocks will have over A$5m or more than 3x ADV to...

Logo
698 Views
Share
bullish•Lasertec Corp
•10 Sep 2023 06:30

Index Rebalance & ETF Flow Recap: NKY, ASX, CSI300, KOSDAQ150, Yuanta ETFs, MVA, MVW, SMH

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
783 Views
Share
•09 Sep 2023 13:00

MVIS Australia Equal Weight Index Rebalance: Float & Capping Changes

There are no constituent changes, but float/capping will result in one-way turnover of 3.5% and in a one-way trade of A$69m. JB Hi-fi and Charter...

Logo
756 Views
Share
•08 Sep 2023 06:00

ASX Short Interest Weekly (Sep 1st): Mineral Resource, BHP, Fortescue Metals, Macquarie

We analyzed ASX short interest report for the past week and highlight short interest changes in Mineral Resource, BHP, Fortescue Metals, Macquarie,...

Logo
607 Views
Share
x